Company Filing History:
Years Active: 1997
Title: Innovator Spotlight: Maris-Cecile Lenoir and Her Groundbreaking Patent
Introduction: Maris-Cecile Lenoir, an inventive mind based in Valbonne, France, has made significant contributions to the field of dermatological research. With a focus on skin substitutes and tissue engineering, her work stands at the intersection of medical advancements and innovative solutions.
Latest Patents: Maris-Cecile holds a patent for a unique process for creating a skin substitute. This patent details a method that combines contractile cells, a nutritive medium, and collagen to produce a contracting gel, which serves as a dermis substitute. The innovation lies in using this substrate to culture an epidermis substitute derived from keratinocytes sourced from either animal or human skin samples. An additional aspect of her invention involves implanting a section of a hair follicle, which retains some of its cellular sheath, perpendicularly into the substrate. This multifaceted approach aids in developing effective skin substitutes that could revolutionize treatment in dermatology.
Career Highlights: Maris-Cecile is associated with the Centre International de Recherches Dermatologiques, where she has contributed to pioneering research in skin substitute technology. Her dedication to advancing medical science has garnered her recognition within the field, with her patent marking a significant milestone in tissue engineering.
Collaborations: Working alongside Braham Shroot, a fellow researcher, Maris-Cecile has strengthened her impact in the dermatological community. Their collaborative efforts have not only advanced their research but have also fostered an environment for innovative development in skin health solutions.
Conclusion: Maris-Cecile Lenoir exemplifies the spirit of innovation in the realm of dermatological research. Her patent for producing a skin substitute showcases a blend of scientific ingenuity and practical application, poised to make substantial contributions to medical treatments related to skin ailments. As she continues her work at the Centre International de Recherches Dermatologiques, the potential for further advancements in her field remains promising.